KLING DOUGLAS F

PrivateCIK: 1699022
Location

BEDMINSTER, NJ

KLING DOUGLAS F (Chief Operating Officer) sold 69.4% of their position (100K shares) of NEWAMSTERDAM PHARMA CO N.V. on the open market

Open‑market sale worth $1.93M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 2 sales
InsiderKLING DOUGLAS FCIK 1699022
Officer· Chief Operating Officer
Since Dec 2023
-100K
Net shares
Net seller
$1.93M
Total sold
2
Open market trades
0B · 2S
6
Total transactions
100K acquired · 200K disposed
Non-Derivative Transactions4

Ordinary Shares

Direct
M · Option Exercise

Shares

+78.10K

Price / share

$10.00

Trade value

$781.01K

% of position

177.5%
6/16/2025
44K122.10K

Ordinary Shares

Direct
M · Option Exercise

Shares

+21.90K

Price / share

$10.90

Trade value

$238.70K

% of position

17.9%
6/16/2025
122.10K144K

Ordinary Shares

Direct
S · Sale

Shares

81.89K

Price / share

$19.19

Trade value

$1.57M

% of position

56.9%
6/16/2025
144K62.11K

Ordinary Shares

Direct
S · Sale

Shares

18.11K

Price / share

$19.75

Trade value

$357.65K

% of position

29.2%
6/16/2025
62.11K44K
Total

Net shares

+0.00

Net value

-$909.43K

Derivative Transactions2

Option (right to buy)

Direct
M · Option Exercise
Converts to

Ordinary Shares

78.10K shares

Shares

78.10K

Strike price

10.00

Held after

372.83K

Exercisable

6/16/2025

Option (right to buy)

Direct
M · Option Exercise
Converts to

Ordinary Shares

21.90K shares

Shares

21.90K

Strike price

10.90

Held after

261.31K

Exercisable

6/16/2025
KLING DOUGLAS F — Insider Transaction (Form 4) Filed Jun 18, 2025 | Finecho